tiprankstipranks
Trending News
More News >

Viavi price target lowered to $11 from $12 at B. Riley

B. Riley analyst Dave Kang lowered the firm’s price target on Viavi (VIAV) to $11 from $12 and keeps a Neutral rating on the shares. The company’s outlook is below consensus due to tariff uncertainty, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1